BUZZ-Clorox slides after disappointing results, downbeat sales forecast

Reuters
06 May
BUZZ-Clorox slides after disappointing results, downbeat sales forecast

** Shares of Clorox CLX.N down 3.6% at $133.38, a nine-mth low, after cleaning product maker's fiscal Q3 results disappointed Wall Street and it cut 2025 sales outlook

** Oakland, California-based Pine-Sol parent late Mon posted adj EPS of $1.45 on rev of $1.67 bln, shy of the $1.57 in earnings and $1.73 bln in rev anticipated by analysts, per LSEG

** Co trimmed annual sales forecast as consumer demand weakens amid economic uncertainty spurred by U.S. President Donald Trump's tariffs

** For fiscal 2025, it anticipates sales to be down 1% to flat, compared with its earlier target of down 1% to up 2%

** At least 6 brokerages cut their PTs reacting to the news, including JP Morgan, BofA Global Research and Morgan Stanley

** JP Morgan said it remains on the sidelines, pointing to expected pull forward benefit reversal in first half of fiscal 2026, continued high promotions in some categories

** BofA said new PT of $145 (down from $150) fairly balances CLX's near-term volume recovery amid increasingly challenged consumer backdrop against improved margin trajectory post-cyberattack

** Of 21 brokerages covering CLX, recommendation breakdown is 3 "strong buy" or "buy", 14 "hold" and 4 "sell"; median PT of $147 down from $165 a month ago - LSEG

** With move on the session, stock down ~18% YTD vs S&P 500 Consumer Staples sector's .SPLRCS 5% advance

(Lance Tupper is a Reuters market analyst. The views expressed are his own)

((lance.tupper@tr.com 1-646-279-6380))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10